3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...

3/4/2026Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...

3/4/2026Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with UCB

3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...

3/3/2026Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...

3/3/2026Rallybio to Merge with Candid Therapeutics in $505M-Funded Reverse Mer...

3/3/2026Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...

3/2/2026RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA

3/2/2026MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China

3/2/2026QL Biopharm Raises Over CNY 500M in Series C Led by OrbiMed

3/2/2026NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...

3/2/2026WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform

2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China

2/27/2026Duality Reports Updated DB-1311/BNT324 Data at ASCO GU 2026

2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...

2/25/2026CASI Pharma to Be Delisted from Nasdaq, Shares to Move to OTC Market

2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...

2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...

2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...

2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...

2/24/2026Frontier Biotech Inks Global siRNA Licensing Deal with GSK

2/24/2026XtalPi and YolTech Forge AI Alliance to Advance mRNA and In Vivo CAR-T...

2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy

2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought

2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer

2/16/2026FindCure Secures CNY 100M+ Series B to Accelerate Cancer Therapy Progr...

2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...

2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application

2/13/2026ProteLight Pharmaceuticals Files Hong Kong IPO application

2/13/2026VivaVision Files Hong Kong IPO to Fund Late-Stage Ophthalmology Progra...

Page:1/26 Total number of articles:753: [First][<<] [1] [2] [3] [4] [5] [>>] [End]